Novel metabolic products of cyclophosphamide in human urine.
D000818:Animals; D002277:Carcinoma / Q000188:drug therapy; D002279:Carcinoma 256, Walker; D002478:Cells, Cultured; D002855:Chromatography, Thin Layer; D003520:Cyclophosphamide / Q000031:analogs & derivatives / Q000378:metabolism* / Q000494:pharmacology; D005260:Female; D006801:Humans; D013058:Mass Spectrometry; D009588:Nitrogen Mustard Compounds / Q000633:toxicity / Q000652:urine; D010051:Ovarian Neoplasms / Q000188:drug therapy; D010080:Oxazoles / Q000633:toxicity / Q000652:urine; D010761:Phosphorus Radioisotopes; D010879:Piperazines / Q000633:toxicity / Q000652:urine
D009588:Nitrogen Mustard Compounds; D010080:Oxazoles; D010761:Phosphorus Radioisotopes; D010879:Piperazines; D003520:Cyclophosphamide